We are live on ! Find out more
DWTX

Dogwood Therapeutics
DWTX

13 hedge funds and large institutions have $7.64M invested in Dogwood Therapeutics in 2026 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,516% more capital invested

Capital invested by funds: $292K → $7.64M (+$7.35M)

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

30% more funds holding

Funds holding: 10 → 13 (+3)

7.78% more ownership

Funds ownership: 3.06% → 10.84% (+7.8%)

Holders
13
Holders Change
+3
Holders Change %
+30%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
3
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$9.65M
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$184K
3
Northern Trust
Northern Trust
Illinois
+$70K
4
Goldman Sachs
Goldman Sachs
New York
+$43K
5
TRCT
Tower Research Capital (TRC)
New York
+$23.7K

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$39.2K
2
Morgan Stanley
Morgan Stanley
New York
-$1.98K

DWTX Hedge Fund Activity: Q1 2026 in Review

13 of the 8,203 institutional investors tracked by Wall St. Rank reported a position in Dogwood Therapeutics (DWTX) for Q1 2026, worth a combined $7.64M — up 2,516% from $292K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new DWTX positions and 2 closed out — a net gain of 4 holders — while 3 added to existing stakes and 0 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $9.65M. The largest seller was Bank of America, exiting entirely with an estimated $39.2K sold.

  • 13 institutional investors held Dogwood Therapeutics (DWTX) as of Q1 2026, up from 10 in Q4 2025.
  • Funds reported $7.64M of Dogwood Therapeutics stock for Q1 2026, up 2,516% quarter-over-quarter.
  • 6 funds opened new Dogwood Therapeutics positions in Q1 2026 and 2 closed out, a net change of +4 holders.
  • The largest Dogwood Therapeutics buyer in Q1 2026 was Armistice Capital, an estimated $9.65M added.
  • The largest Dogwood Therapeutics seller in Q1 2026 was Bank of America, an estimated $39.2K sold.

Based on aggregated 13F filings for Q1 2026.